Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 873428

Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.


Ristić, Smiljana; Starčević Čizmarević, Nada; Lavtar, Polona; Lovrečić, Luca; Perković, Olivio; Sepčić, Juraj; Šega Jazbec, Saša; Kapović, Miljenko; Peterlin, Borut.
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report. // Pharmacogenetics and Genomics, 27 (2017), 6; 232-235 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 873428 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.

Autori
Ristić, Smiljana ; Starčević Čizmarević, Nada ; Lavtar, Polona ; Lovrečić, Luca ; Perković, Olivio ; Sepčić, Juraj ; Šega Jazbec, Saša ; Kapović, Miljenko ; Peterlin, Borut.

Izvornik
Pharmacogenetics and Genomics (1744-6872) 27 (2017), 6; 232-235

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Angiotensin-converting enzyme, Angiotensin-converting enzyme insertion/deletion polymorphism, Interferon-β, Multiple sclerosis, Treatment response

Sažetak
We investigated the effect of the functional insertion/ deletion (I/D) polymorphism in the angiotensin- converting enzyme (ACE) gene on the response to interferon-β (IFN-β) therapy in Croatian and Slovenian patients with multiple sclerosis (MS). A total of 275 IFN-β treated MS patients [162 responders (Rs) and 113 nonresponders (NRs)] were genotyped by PCR. The ACE I/D genotype distribution and allele frequencies did not differ between female Rs and NRs. However, male NRs tended to have a greater prevalence of the DD genotype (P=0.073 ; odds ratio: 2.64 ; 95% confidence interval: 0.91–7.60) and a significantly higher frequency of the D allele (P=0.022 ; odds ratio: 2.43 ; 95% confidence interval: 1.13–5.20) than male Rs. Multiple forward stepwise regression analysis indicated that the negative response to IFN-β therapy was associated with the ACE-DD genotype in men ( β=0.371 ; multiple R2 change: 0.132 ; P=0.009) and a higher pretreatment relapse rate in both men ( β=−0.438 ; multiple R2 change: 0.135 ; P=0.015) and women ( β=−0.208 ; multiple R2 change: 0.042 ; P=0.034). The ACE I/D polymorphism and pretreatment relapse rate accounted for ∼26.7% of the IFN-β response variability among the men in the sample. Further studies of a larger number of MS patients from different populations are necessary to evaluate these preliminary findings.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Fakultet zdravstvenih studija u Rijeci

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada

Citiraj ovu publikaciju:

Ristić, Smiljana; Starčević Čizmarević, Nada; Lavtar, Polona; Lovrečić, Luca; Perković, Olivio; Sepčić, Juraj; Šega Jazbec, Saša; Kapović, Miljenko; Peterlin, Borut.
Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report. // Pharmacogenetics and Genomics, 27 (2017), 6; 232-235 (međunarodna recenzija, članak, znanstveni)
Ristić, S., Starčević Čizmarević, N., Lavtar, P., Lovrečić, L., Perković, O., Sepčić, J., Šega Jazbec, S., Kapović, M. & Peterlin, B. (2017) Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.. Pharmacogenetics and Genomics, 27 (6), 232-235.
@article{article, author = {Risti\'{c}, Smiljana and Star\v{c}evi\'{c} \v{C}izmarevi\'{c}, Nada and Lavtar, Polona and Lovre\v{c}i\'{c}, Luca and Perkovi\'{c}, Olivio and Sep\v{c}i\'{c}, Juraj and \v{S}ega Jazbec, Sa\v{s}a and Kapovi\'{c}, Miljenko and Peterlin, Borut.}, year = {2017}, pages = {232-235}, keywords = {Angiotensin-converting enzyme, Angiotensin-converting enzyme insertion/deletion polymorphism, Interferon-β, Multiple sclerosis, Treatment response}, journal = {Pharmacogenetics and Genomics}, volume = {27}, number = {6}, issn = {1744-6872}, title = {Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.}, keyword = {Angiotensin-converting enzyme, Angiotensin-converting enzyme insertion/deletion polymorphism, Interferon-β, Multiple sclerosis, Treatment response} }
@article{article, author = {Risti\'{c}, Smiljana and Star\v{c}evi\'{c} \v{C}izmarevi\'{c}, Nada and Lavtar, Polona and Lovre\v{c}i\'{c}, Luca and Perkovi\'{c}, Olivio and Sep\v{c}i\'{c}, Juraj and \v{S}ega Jazbec, Sa\v{s}a and Kapovi\'{c}, Miljenko and Peterlin, Borut.}, year = {2017}, pages = {232-235}, keywords = {Angiotensin-converting enzyme, Angiotensin-converting enzyme insertion/deletion polymorphism, Interferon-β, Multiple sclerosis, Treatment response}, journal = {Pharmacogenetics and Genomics}, volume = {27}, number = {6}, issn = {1744-6872}, title = {Angiotensin-converting enzyme insertion/deletion gene polymorphism and interferon-β treatment response in multiple sclerosis patients: a preliminary report.}, keyword = {Angiotensin-converting enzyme, Angiotensin-converting enzyme insertion/deletion polymorphism, Interferon-β, Multiple sclerosis, Treatment response} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font